A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid Arthritis

Authors
Category Primary study
Registry of TrialsClinical Trials Peruvian Registry
Year 2009
This article has no abstract
Epistemonikos ID: 3a711ac6eb8d608681ec9da5454398d9307597d6
First added on: Apr 16, 2025